<?xml version="1.1" encoding="utf-8"?>
<rdf:RDF xmlns:OMEXlib="http://omex-library.org/"
   xmlns:bqbiol="http://biomodels.net/biology-qualifiers/"
   xmlns:bqmodel="http://biomodels.net/model-qualifiers/"
   xmlns:dc="http://purl.org/dc/terms/"
   xmlns:foaf="http://xmlns.com/foaf/0.1/"
   xmlns:local="http://omex-library.org/NewOmex.omex/NewModel.rdf#"
   xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
  <rdf:Description rdf:about="http://omex-library.org/BIOMD0000000624.omex">
    <bqmodel:isDescribedBy rdf:resource="local:00001"/>
    <ns1:keyword xmlns:ns1="http://prismstandard.org/namespaces/basic/2.0/">Biomodels</ns1:keyword>
    <ns2:description xmlns:ns2="http://purl.org/dc/elements/1.1/">&lt;body xmlns="http://www.w3.org/1999/xhtml"&gt;
  &lt;div class="dc:title"&gt;Sluka2016 - Acetaminophen metabolism&lt;/div&gt;
  &lt;div class="dc:description"&gt;
    &lt;b&gt;Liver metabolism of Acetaminophen:&lt;/b&gt; Acetaminophen (APAP) is
metabolized in the liver in both Phase I and Phase II reactions.
Phase II reactions convert APAP to APAP-glucuronide and
APAP-sulfate. Phase I reactions involve Cytochrome P450 mediated
(mostly Cyp450-2E1 and -1A2) conversion of APAP to
N-acetyle-p-quinoneimine (NAPQI), which goes on to react with
cellular nucleophiles such as glutathione (GSH). At high doses of
APAP significant GSH depletion in hepatocyte occurs resulting in
cell necrosis and and in extreme cases death.&lt;/div&gt;
    &lt;div class="dc:bibliographicCitation"&gt;
      &lt;p&gt;This model is described in the article:&lt;/p&gt;
      &lt;div class="bibo:title"&gt;
        &lt;a href="http://identifiers.org/pubmed/27636091" title="Access to this publication"&gt;A Liver-Centric Multiscale
    Modeling Framework for Xenobiotics.&lt;/a&gt;
      &lt;/div&gt;
      &lt;div class="bibo:authorList"&gt;Sluka JP, Fu X, Swat M, Belmonte JM,
  Cosmanescu A, Clendenon SG, Wambaugh JF, Glazier JA.&lt;/div&gt;
      &lt;div class="bibo:Journal"&gt;PLoS ONE 2016; 11(9): e0162428&lt;/div&gt;
      &lt;p&gt;Abstract:&lt;/p&gt;
      &lt;div class="bibo:abstract"&gt;
        &lt;p&gt;We describe a multi-scale, liver-centric in silico modeling
    framework for acetaminophen pharmacology and metabolism. We
    focus on a computational model to characterize whole body
    uptake and clearance, liver transport and phase I and phase II
    metabolism. We do this by incorporating sub-models that span
    three scales; Physiologically Based Pharmacokinetic (PBPK)
    modeling of acetaminophen uptake and distribution at the whole
    body level, cell and blood flow modeling at the tissue/organ
    level and metabolism at the sub-cellular level. We have used
    standard modeling modalities at each of the three scales. In
    particular, we have used the Systems Biology Markup Language
    (SBML) to create both the whole-body and sub-cellular scales.
    Our modeling approach allows us to run the individual
    sub-models separately and allows us to easily exchange models
    at a particular scale without the need to extensively rework
    the sub-models at other scales. In addition, the use of SBML
    greatly facilitates the inclusion of biological annotations
    directly in the model code. The model was calibrated using
    human in vivo data for acetaminophen and its sulfate and
    glucuronate metabolites. We then carried out extensive
    parameter sensitivity studies including the pairwise
    interaction of parameters. We also simulated population
    variation of exposure and sensitivity to acetaminophen. Our
    modeling framework can be extended to the prediction of liver
    toxicity following acetaminophen overdose, or used as a general
    purpose pharmacokinetic model for xenobiotics.&lt;/p&gt;
      &lt;/div&gt;
    &lt;/div&gt;
    &lt;div class="dc:publisher"&gt;
      &lt;p&gt;This model is hosted on 
  &lt;a href="http://www.ebi.ac.uk/biomodels/"&gt;BioModels Database&lt;/a&gt;
  and identified by: 
  &lt;a href="http://identifiers.org/biomodels.db/BIOMD0000000624"&gt;BIOMD0000000624&lt;/a&gt;.&lt;/p&gt;
      &lt;p&gt;To cite BioModels Database, please use: 
  &lt;a href="http://identifiers.org/pubmed/20587024" title="Latest BioModels Database publication"&gt;BioModels Database:
  An enhanced, curated and annotated resource for published
  quantitative kinetic models&lt;/a&gt;.&lt;/p&gt;
    &lt;/div&gt;
    &lt;div class="dc:license"&gt;
      &lt;p&gt;To the extent possible under law, all copyright and related or
  neighbouring rights to this encoded model have been dedicated to
  the public domain worldwide. Please refer to 
  &lt;a href="http://creativecommons.org/publicdomain/zero/1.0/" title="Access to: CC0 1.0 Universal (CC0 1.0), Public Domain Dedication"&gt;CC0
  Public Domain Dedication&lt;/a&gt; for more information.&lt;/p&gt;
    &lt;/div&gt;
  &lt;/body&gt;</ns2:description>
    <ns3:title xmlns:ns3="http://purl.org/dc/elements/1.1/">A Liver-Centric Multiscale Modeling Framework for Xenobiotics</ns3:title>
  </rdf:Description>
  <rdf:Description rdf:about="local:00001">
    <ns4:identifier xmlns:ns4="http://purl.org/dc/elements/1.1/"
       rdf:resource="http://identifiers.org/doi/10.1371/journal.pone.0162428"/>
    <ns5:label xmlns:ns5="http://www.w3.org/2000/01/rdf-schema#">James P. Sluka, Xiao Fu, Maciej Swat, Julio M. Belmonte, Alin Cosmanescu, Sherry G. Clendenon, John F. Wambaugh &amp; James A. Glazier. A Liver-Centric Multiscale Modeling Framework for Xenobiotics. PLOS ONE 11, 9 (2016).</ns5:label>
  </rdf:Description>
</rdf:RDF>

